Vanderbilt Health News Archive — Page 124 of 390
-
July 16, 2020
Investigational glaucoma drug studied to prevent respiratory distress in COVID-19 patients
Vanderbilt University Medical Center is evaluating razuprotafib, a drug being investigated for the treatment of glaucoma, in a new randomized, investigational trial for the prevention and treatment of acute respiratory distress syndrome (ARDS) in adult patients with moderate to severe COVID-19. -
July 9, 2020
About half of health care workers positive for COVID-19 by serology have no symptoms
The IVY Research Network has completed initial studies evaluating the epidemiology of COVID-19 in health care workers and patients. -
July 9, 2020
Recurrent UTIs linked to hidden reservoir
Bacterial invasion of vaginal cells sets up a protective niche and a reservoir for recurrent urinary tract infections, Vanderbilt researchers demonstrated. -
July 6, 2020
New physician spotlight: Martin Montenovo
Martin Montenovo, MD, a liver transplant surgeon, has joined Vanderbilt University Medical Center as associate professor of Surgery in the Division of Hepatobiliary Surgery & Liver Transplantation. He began seeing patients on September 1, 2019. -
July 3, 2020
Research team isolates antibodies that may prevent rare polio-like illness in children linked to a respiratory infection
Researchers at Vanderbilt University Medical Center, Purdue University and the University of Wisconsin-Madison have isolated human monoclonal antibodies that potentially can prevent a rare but devastating polio-like illness in children linked to a respiratory viral infection. -
July 2, 2020
Slayton named Senior Vice President for Quality, Safety and Risk Prevention
Jenny Slayton, MSN, RN, who has served as Vice President of Quality, Safety and Risk Prevention since 2016, is being promoted to Senior Vice President for Quality, Safety and Risk Prevention.